Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial

EBioMedicine(2023)10.1016/j.ebiom.2023.104902Source: DataRank Database

Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial is a research paper published in EBioMedicine (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.23)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sanjay J. Mathew ORCID,Robert H. Howland ORCID,Angela Griffo ORCID,Benjamin Panny ORCID,Rebecca B. Price ORCID

Live enrichment

PubMed:38141395 PMC:PMC10788398 OpenAlex:https://openalex.org/W4390095431

NIMH

Grant: R01MH113857

University of Pittsburgh

Grant: UL1-TR-001857

NCATS NIH HHS

Grant: UL1 TR001857

National Institutes of Health

Grant: 5R01MH113857-02

Testing a Synergistic, Neuroplasticity-Based Intervention for Depressive Neurocognition

National Institutes of Health

Grant: 3UL1TR001857-07S1

University of Pittsburgh Clinical and Translational Science Institute

National Institutes of Health

FWCI

2.23

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2352396423004681/pdf

publisherhttp://www.thelancet.com/article/S2352396423004681/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396423004681?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396423004681?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2023.104902

Fields of Study

Treatment of Major DepressionFunctional Brain Connectivity StudiesTryptophan and brain disorders03 medical and health sciences0302 clinical medicineAdultMaleFemaleAnimalsHumansKetamineAntidepressive AgentsDepressionPrefrontal CortexTreatment OutcomeRandomized Controlled Trials as Topic

MeSH Terms

AdultAnimalsAntidepressive AgentsDepressionFemaleHumansKetamineMaleRandomized Controlled Trials as TopicTreatment OutcomePrefrontal Cortex

Keywords

KetamineNeuroplasticityRandomized controlled trialNeuroscienceMoodContext (archaeology)MedicinePrefrontal cortexPsychologyAnesthesiaInternal medicinePsychiatryCognitionBiologyRctResting-stateNeural ConnectivityPositive Mood InductionAdultMaleDepressionArticlesAntidepressive AgentsTreatment OutcomeAnimalsHumansFemaleRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 0: Good health and well-being

Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)